Michael Merson
Wolfgang Joklik Distinguished Professor Emeritus of Global Health
Professor Emeritus of Medicine
Adjunct Professor of Global Health
Appointment:
Countries:
Michael Merson
Wolfgang Joklik Distinguished Professor Emeritus of Global Health
Professor Emeritus of Medicine
Adjunct Professor of Global Health
Michael Merson was the Wolfgang Joklik Professor of Medicine and Professor of Global Health at Duke University. He was the founding director of the Duke Global Health Institute and of the SingHealth Duke-NUS Global Health Institute. He served as Vice President and Vice Provost for Global Affairs at Duke University and as Vice Chancellor for Duke-National University of Singapore Affairs. He is also Visiting Professor of Global Health at NYU School of Global Public Health.
Dr. Merson served as director for the World Health Organization (WHO) programs on Diarrheal Diseases and Acute Respiratory Infections, and subsequently the WHO Global Program on AIDS. After WHO, he joined Yale University as its first Dean of Public Health and the Anna M. R. Lauder Professor of Public Health. He also was the Director of the Center for Interdisciplinary Research on AIDS at Yale University.
Dr. Merson is currently involved in policy related research related to the COVID-19 pandemic, is a member of a leadership team undertaking pilot projects on use of Paxlovid in sub-Saharan Africa, and is engaged in an initiative that is seeking to build trust in public health.
He has authored over 180 articles, is the senior editor of the leading global health textbook “Global Health: Disease, Programs, Systems, and Policies” and co-author of The AIDS Pandemic: Searching for a Global Response on the history of the global response to AIDS. He has served in advisory capacities for UNAIDS, WHO, the Global Fund to Fight AIDS, TB and Malaria, World Bank, World Economic Forum, Bill & Melinda Gates Foundation, and most recently been an advisor to various private sector entities on the COVID-19 pandemic. He has two honorary degrees and is a member of the National Academy of Medicine.
Projects
-
COVID Treatment Quick Start Consortium
Kenya, Laos, Malawi, Rwanda, South Africa, Uganda, United States, Zambia, Zimbabwe
-
COVID Global Accountability Platform (COVID GAP)
United States
- Control of Childhood Diarrhea Mortality: Past Success and Future Prospects
Publications
-
Tai CG, Haviland MJ, Kissler SM, Lucia RM, Merson M, Maragakis LL, et al. Low antibody levels associated with significantly increased rate of SARS-CoV-2 infection in a highly vaccinated population from the US National Basketball Association. In: Journal of Medical Virology. 2024.Mack CD, Merson MH, Sims L, Maragakis LL, Davis R, Tai CG, et al. The "Bubble": What Can Be Learned from the National Basketball Association (NBA)'s 2019-20 Season Restart in Orlando during the COVID-19 Pandemic. J Appl Lab Med. 2023 Nov 2;8(6):1017–27.STAGE (Strategic Technical Advisory Group of Experts), Duke T, AlBuhairan FS, Agarwal K, Arora NK, Arulkumaran S, et al. World Health Organization and knowledge translation in maternal, newborn, child and adolescent health and nutrition. Arch Dis Child. 2022 Jul;107(7):644–9.Mack CD, Tai C, Sikka R, Grad YH, Maragakis LL, Grubaugh ND, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Series From a 12-Month Longitudinal Occupational Cohort. Clin Infect Dis. 2022 May 3;74(9):1682–5.
See more publications at Scholars@Duke